News Introduction

3,4-Dihydroxybenzaldehyde(cas 139-85-5) and the deveopment of pharmaceutical industrial

Date : 2016/8/18 11:11:00

3,4-Dihydroxybenzaldehyde(cas 139-85-5) is one of the active ingredients of pharmaceutical. Pharmaceutical firms are called never fading sunrise industry, the future trend of the overall development of the pharmaceutical industry is very clear, the aging population, urbanization, health awareness and expanding the spectrum of disease has prompted medical needs continue to grow; the development of biotechnology is such technically able to guarantee the supply of innovative pharmaceutical research and development, to meet the needs of medicine; and government spending on health care is increasing funding provided to meet the demand. "Thirteen Five" period will be a critical period of development of the pharmaceutical industry, it will also be of strategic opportunities promising industry.

Since the pharmaceutical manufacturing industry of high investment, high risk, high return, long development cycle development characteristics, promote the development of the industry must achieve three major gathering: to the park gathering, economically developed areas to gather, to gather professional intelligence-intensive areas. Therefore, the current regional characteristics Chinese medicine manufacturing industry are: gathering in the eastern coastal areas of concentrated research institutes and innovative ability and a few provinces in central and western center of the city, the initial formation of the Yangtze River Delta, the Bohai Sea as the core, the Pearl River Delta, spatial pattern of rapid development in the eastern region of the Northeast.

The first half of 2015, China's above-scale pharmaceutical industrial added value grew 9.9%, pharmaceutical industrial enterprises above designated size main business income of 1.235561 trillion yuan, an increase of 8.91%, higher than the national growth rate of 7.51 percentage points overall industry. Successively promulgated the "People's Republic of China Pharmacopoeia", "on the issuance of enhanced drug price reform views of the notice", "on the reform of Drugs and Medical Devices evaluation and approval system view" and other pharmaceutical policy, to further standardize the market of pharmaceutical development mechanism, promote the pharmaceutical industry healthy and orderly development.

Basic chemical raw materials is the upstream of pharmaceutical intermediates, and pharmaceutical raw materials is the of downstream pharmaceutical intermediates. Basic chemical raw materials, pharmaceutical intermediates, pharmaceutical raw materials and manufacturing pharmaceutical chemical and pharmaceutical industry constitute a complete industrial chain. 3,4-Dihydroxybenzaldehyde(cas 139-85-5) is one of the composition  in pharmaceutical that has an anti-inflammatory effect of  pharmaceutical composition.